CMA statement on Supreme Court's order granting stay in medication abortion case Donaldo Hernandez, M.D., the president of the California Medical Association (CMA), issued the following statement in response to the Supreme Court order granting a stay in the lawsuit against the U.S. Food and Drug Administration (FDA) over its approval of mifepristone. “The U.S. Supreme Court’s order today to stay the lower court rulings is great news, as it means mifepristone will remain available in the interim for the lives and welfare of millions of people who might need this drug that has been FDA-approved as safe and effective for 23 years. “As ... April 24, 2023 CMA, Drug Prescribing/Dispensing, Healthcare, legislation, Patient Care FDA, Reproductive RIghts 0 0 Comment Read More »
FDA/CDC Warn Against Use of Ivermectin to Prevent and Treat COVID-19 The Centers for Disease Control and Prevention (CDC) has issued a health alert warning physicians and the public about the rise in prescriptions for the anti-parasitic drug ivermectin for use in the treatment or prevention of COVID-19. The CDC also cautioned about the risk of severe illness caused by ivermectin, which was seen in increased calls to poison centers. Current NIH Treatment Guidelines state that there is insufficient evidence to recommend either for or against the use of ivermectin for the treatment of COVID-19 outside of clinical trials. This recommendation is ... August 31, 2021 COVID19, Drug Prescribing/Dispensing CDC, COVID-19, FDA, Ivermectin, Prescriptions 0 0 Comment Read More »
Effect of Graphic Warning Labels on Cigarette Packs on US Smokers’ Cognitions and Smoking Behavior After 3 Months, A Randomized Clinical Trial Abstract Importance The US Food and Drug Administration’s implementation of graphic warning labels (GWLs) on cigarette packs is under challenge in US courts. Objective To determine whether GWLs can affect US smokers’ perceptions about their cigarettes or health consequences and changes in smoking behavior. Design, Setting, and Participants This study was a randomized clinical trial of the effect of a 3-month, real-world experience of cigarettes with GWL packaging. Community recruitment was done from September 2016 through December 2019 of daily smokers from San Diego, California, aged 21 to 65 years, who were not ready to ... August 10, 2021 General, Public Health Cigarette, FDA, Warning Labels 0 0 Comment Read More »
